NanoViricides Inc.
Symbol: NNVC (NYSE)
1.42
▼ (-1.67%) -0.024
Company Description:
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Key Stats
- Today's Open: $1.415
- Today's High: $1.44
- Today's Low: $1.415
- Today's Volume: 100
- Yesterday Close: $1.44
- Yesterday High: $1.5
- Yesterday Low: $1.4
- Yesterday Volume: 476.48K
- Last Min Volume: 0
- Last Min High: $1.436
- Last Min Low: $1.416
- Last Min VWAP: $0
Company Profile
- Name: NanoViricides Inc.
- Website: https://www.nanoviricides.com
- Listed Date: 2005-07-05
- Location: SHELTON, CT
- Market Status: Active
- CIK Number: 0001379006
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $25.80M
- Round Lot: 100
- Outstanding Shares: 17.43M
- Asset Type: CS
RECENT FILINGS FOR NNVC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-08 | DEF 14A | View |
| 2025-10-01 | 8-K | View |
| 2025-09-29 | 10-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-02-14 | 10-Q | View |
| 2025-01-28 | 4 | View |
| 2024-12-12 | 8-K | View |
| 2024-11-14 | 10-Q | View |
| 2024-10-15 | DEF 14A | View |
| 2024-09-27 | 10-K | View |
| 2024-08-09 | 8-K | View |
| 2024-08-09 | 424B5 | View |
| 2024-05-15 | 10-Q | View |
| 2024-05-13 | UPLOAD | View |
| 2024-05-08 | CORRESP | View |
| 2024-04-22 | UPLOAD | View |
| 2024-04-09 | CORRESP | View |
| 2024-04-05 | 8-K | View |
| 2024-04-05 | 424B5 | View |
| 2024-02-16 | 8-K | View |